Abstract
Background Rhodesiense human African trypanosomiasis (r-HAT) remains a public health problem in Malawi, with the country reporting the highest number of cases of this acute form of sleeping sickness in the East African endemic region in 2019 and 2020. This paper explores the bottlenecks to seeking health care among patients with r-HAT around the Vwaza Marsh Wildlife Reserve (VMWR) in Rumphi and Mzimba districts in northern Malawi.
Methodology/Principal Findings This qualitative study used key informant interviews (KIIs), in-depth interviews (IDIs) and focus group discussions (FGDs) to collect data. Study participants included health care workers, current and past r-HAT patients and their guardians, community leaders and traditional healers. All interviews were audio-recorded and transcribed verbatim. Content analysis was performed with NVIVO. Since r-HAT has similar signs and symptoms to malaria, patients either self-medicate or are prescribed antimalarial treatment, delaying the initiation of r-HAT treatment. While diagnosis of r-HAT can be done at health centre level, treatment requires hospitalization at the district hospital situated 60 kilometers away. Due to high levels of poverty, patients struggle to afford transport to the district hospital and their upkeep during hospitalization; patients and their guardians explained how they sold their property to fund this. In addition, patients fear undergoing very painful diagnostic lumbar puncture, which is very painful. Belief that r-HAT is caused by witchcraft still prevails, which also delays initiation of treatment. The delivery of r-HAT services is also affected by the transfer of trained health workers to other locations.
Conclusions/Significance Access to r-HAT services, including treatment, could improve if community members were sensitized about the causes, signs and symptoms of the disease, and the fact that it can be effectively treated at hospital but not by traditional healers. Provision of treatment for r-HAT by health facilities around the VMWR would eliminate transport costs for patients and their guardians.
Author Summary Since 2019, Malawi has reported the highest numbers of cases of rhodesiense human African trypanosomiasis. This study found that patients and their families experience many challenges in seeking health care: the disease is misdiagnosed as malaria, leading to patients receiving the wrong treatment and late initiation of the right treatment; beliefs in witchcraft cause delays as patients seek treatment from traditional healers; high levels of poverty mean that patients struggle to fund transport to the district hospital, the only facility currently providing treatment, and their upkeep during periods of hospitalization; fear of undergoing the very painful diagnostic lumbar puncture; and the transfer of well-trained health workers away from the area. There is a need to create awareness about the causes, treatment, and prevention of sleeping sickness. Once patients are diagnosed with this disease, they should be advised to seek treatment from the hospital and not from traditional healers. Patients should also be able to access treatment at the nearby health facilities rather than the district hospital, which is situated a long way from the community.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
DNDi is grateful to the following donors for funding this project: European and Developing Countries Clinical Trials Partnership (EDCTP2) programme supported by the European Union (grant HAT-r-ACC, RIA2017NCT-1846) https://www.edctp.org/ Fundação para a Ciência e a Tecnologia (FCT), Portugal https://www.fct.pt/ Swiss Agency for Development and Cooperation (SDC) https://www.eda.admin.ch/sdc UK aid, UK https://www.ukaiddirect.org/ Médecins Sans Frontières International https://www.msf.org and other private foundations and individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Malawi Research Ethics Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
Data contain potentially identifying or sensitive information about the participants in the study. The first author may be contacted for any further requests.
